These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2380800)

  • 21. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards.
    Hosp Pharm; 1981 Jan; 16(1):17-20. PubMed ID: 10249749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration.
    Yodaiken RE; Bennett D
    Am J Hosp Pharm; 1986 May; 43(5):1193-204. PubMed ID: 3717176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacy practitioners' adherence to safe-handling practices of chemotherapeutic drugs: A cross-sectional study in Saudi Arabia.
    Ogbaghebriel A; Alshamrani M; Ibrahim A; Al-Masaary W; Hakami S; Alrasheed S; Al-Sayed N
    J Oncol Pharm Pract; 2022 May; ():10781552221105584. PubMed ID: 35642271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental and direct measures of exposure.
    Valanis B
    Occup Med; 1986; 1(3):431-44. PubMed ID: 3299787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of personal protective equipment under occupational exposure to cytostatics].
    Krzemińska S; Pośniak M; Szewczyńska M
    Med Pr; 2016; 67(4):499-508. PubMed ID: 27623830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of potential exposure to antineoplastic agents in the health care setting.
    Stellman JM; Aufiero BM; Taub RN
    Prev Med; 1984 May; 13(3):245-55. PubMed ID: 6494107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality-assurance testing of staff pharmacists handling cytotoxic agents.
    Harrison BR; Godefroid RJ; Kavanaugh EA
    Am J Health Syst Pharm; 1996 Feb; 53(4):402-7. PubMed ID: 8673660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current challenges in European oncology pharmacy practice.
    Hoppe-Tichy T
    J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing employee apprehension toward handling cytotoxic drugs.
    Moore TD; Hale KM; Cortese LM; Fillmore AD; Jozefczyk KG; Scala SM; Wellman GS
    Am J Hosp Pharm; 1985 Apr; 42(4):826-31. PubMed ID: 4014233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injectable-antineoplastic-drug practices in Michigan hospitals.
    Cohen IA; Newland SJ; Kirking DM
    Am J Hosp Pharm; 1987 May; 44(5):1096-105. PubMed ID: 3605120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technical considerations in the preparation and dispensing of chemotherapy.
    Peters BG
    Top Hosp Pharm Manage; 1995 Jan; 14(4):78-88. PubMed ID: 10140430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Justification and implementation of a cancer center pharmacy satellite.
    Sauer KA; Nowak MM; Coons SJ; Parr MD; McIntyre WJ
    Am J Hosp Pharm; 1989 Jul; 46(7):1389-92. PubMed ID: 2757046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for the safe handling of injectable antineoplastic drug products.
    Zimmerman PF; Larsen RK; Barkley EW; Gallelli JF
    Am J Hosp Pharm; 1981 Nov; 38(11):1693-5. PubMed ID: 7304621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service].
    Pacheco Ramos Mde L; Arenaza Peña AE; Santiago Pérez A; Bilbao Gómez-Martino C; Zamora Barrios MD; Arias Fernández ML
    Farm Hosp; 2015 May; 39(3):137-46. PubMed ID: 26005888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staff members' compliance with their facility's antineoplastic drug handling policy.
    Valanis B; McNeil V; Driscoll K
    Oncol Nurs Forum; 1991 Apr; 18(3):571-6. PubMed ID: 2057401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safe handling of antineoplastic drugs. Results of a survey.
    Nieweg RM; de Boer M; Dubbleman RC; Gall HE; Hesselman GM; Lenssen PC; van Maanen LW; Majoor PW; Ouwerkerk J; Slegt JH
    Cancer Nurs; 1994 Dec; 17(6):501-11. PubMed ID: 7820828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeability of four disposable protective-clothing materials to seven antineoplastic drugs.
    Laidlaw JL; Connor TH; Theiss JC; Anderson RW; Matney TS
    Am J Hosp Pharm; 1985 Nov; 42(11):2449-54. PubMed ID: 4073061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for pharmacist management of antineoplastic drug-induced adverse effects in outpatients.
    Horne AL; Dapolite LA
    Am J Health Syst Pharm; 1997 Mar; 54(6):680-3. PubMed ID: 9075498
    [No Abstract]   [Full Text] [Related]  

  • 40. Actual conditions of the mixing of antineoplastic drugs for injection in hospitals in Osaka Prefecture, Japan.
    Yoshida J; Kosaka H; Nishida S; Kumagai S
    J Occup Health; 2008; 50(1):86-91. PubMed ID: 18285651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.